# Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease

> **NCT03717181** · — · NO_LONGER_AVAILABLE · sponsor: **Palladio Biosciences**

## Conditions studied

- Polycystic Kidney

## Interventions

- **DRUG:** Lixivaptan

## Key facts

- **NCT ID:** NCT03717181
- **Lead sponsor:** Palladio Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03717181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03717181, "Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03717181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*